EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines

Sebastian Rask Hamm iD, Josefine Amalie Loft iD, Laura Pérez-Alós iD, Line Dam Heftdal, Cecilie Bo Hansen iD, Dina Leth Møller iD, Mia Marie Pries-Heje, Rasmus Bo Hasselbalch iD, Kamille Fogh, Annemette Hald iD, Sisse Rye Ostrowski iD, Ruth Frikke-Schmidt iD und 10 weitere

Viruses · 2024

DOI: 10.3390/v16060860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Sebastian Rask Hamm und 21 weiteren Autor:innen. Beteiligte Einrichtung: Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark. Hauptthemen laut MEDLINE: BNT162 Vaccine, COVID-19, Antibodies, Viral, Immunity, Humoral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carlsberg Foundation, Novo Nordisk Foundation, Svend Andersen Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As solid organ transplant (SOT) recipients remain at risk of severe outcomes after SARS-CoV-2 infections, vaccination continues to be an important preventive measure. In SOT recipients previously vaccinated with at least three doses of BNT162b2, we investigated humoral responses to BNT162b2 booster doses. Anti-SARS-CoV-2 receptor binding domain (RBD) immunoglobulin G (IgG) was measured using an in-house ELISA. Linear mixed models were fitted to investigate the change in the geometric mean concentration (GMC) of anti-SARS-CoV-2 RBD IgG after vaccination in participants with intervals of more or less than six months between the last two doses of vaccine. We included 107 SOT recipients vaccinated with a BNT162b2 vaccine. In participants with an interval of more than six months between the last two vaccine doses, we found a 1.34-fold change in GMC per month (95% CI 1.25–1.44), while we found a 1.09-fold change in GMC per month (95% CI 0.89–1.34) in participants with an interval of less than six months between the last two vaccine doses, resulting in a rate ratio of 0.82 (95% CI 0.66 to 1.01, p = 0.063). In conclusion, the administration of identical COVID-19 mRNA vaccine boosters within six months to SOT recipients may result in limited humoral immunogenicity of the last dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BNT162 VaccineCOVID-19Antibodies, ViralImmunity, HumoralTransplant RecipientsSARS-CoV-2Immunization, SecondaryImmunoglobulin GOrgan TransplantationCOVID-19 VaccinesHumansMaleFemaleMiddle AgedAgedAdultVaccinationSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

BNT162b2COVID-19SARS-CoV-2boosterimmunogenicitysolid organ transplant recipientvaccine

Substanzen

BNT162 VaccineAntibodies, ViralImmunoglobulin GCOVID-19 VaccinesSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
  • Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Copenhagen University Hospital, 2200 Copenhagen, Denmark.
  • Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
  • Department of Emergency Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Department of Clinical Immunology, Section 2034, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.

ORCID-Profile: Sebastian Rask Hamm, Josefine Amalie Loft, Laura Pérez-Alós, Cecilie Bo Hansen, Dina Leth Møller, Rasmus Bo Hasselbalch, Annemette Hald, Sisse Rye Ostrowski, Ruth Frikke-Schmidt, Peter Garred, Michael Perch, Søren Schwartz Sørensen, Susanne Dam Nielsen

Förderung

  • Carlsberg Foundation
  • Novo Nordisk Foundation
  • Svend Andersen Fonden
  • Research Foundation of Rigshospitalet
  • Svend Andersen Research Foundation

Zitieren

APA

Hamm, S. R., Loft, J. A., Pérez-Alós, L., Heftdal, L. D., Hansen, C. B., Møller, D. L., Pries-Heje, M. M., Hasselbalch, R. B., Fogh, K., Hald, A., Ostrowski, S. R., Frikke-Schmidt, R., Sørensen, E., Hilsted, L., Bundgaard, H., Garred, P., Iversen, K., Perch, M., Sørensen, S. S., …, & Nielsen, S. D. (2024). The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines. Viruses. https://doi.org/10.3390/v16060860

Vancouver

Hamm SR, Loft JA, Pérez-Alós L, Heftdal LD, Hansen CB, Møller DL, et al. The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines. Viruses. 2024. doi:10.3390/v16060860

BibTeX
@article{Hamm2024,
  author = {Hamm, Sebastian Rask and Loft, Josefine Amalie and Pérez-Alós, Laura and Heftdal, Line Dam and Hansen, Cecilie Bo and Møller, Dina Leth and Pries-Heje, Mia Marie and Hasselbalch, Rasmus Bo and Fogh, Kamille and Hald, Annemette and Ostrowski, Sisse Rye and Frikke-Schmidt, Ruth and Sørensen, Erik and Hilsted, Linda and Bundgaard, Henning and Garred, Peter and Iversen, Kasper and Perch, Michael and Sørensen, Søren Schwartz and Rasmussen, Allan and Sabin, Caroline A and Nielsen, Susanne Dam},
  title = {The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16060860}
}
Kostenlos starten →